Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Drug Test Anal ; 15(4): 408-425, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-36541839

RESUMEN

Synthetic cannabinoid receptor agonists (SCRAs) are distributed on the drug market to produce THC-like effects while evading routine drug testing and legislation. The cyclobutylmethyl (CBM) and norbornylmethyl (NBM) side chain specifically circumvented the German legislation and led to the emergence of exploratory SCRAs in 2019-2021. The NBM SCRAs were detected post-amendment of the new psychoactive substances act in 2020, which scheduled all CBM SCRAs. All six SCRAs are full agonists at the cannabinoid receptor 1 compared with Δ9 -tetrahydrocannabinol and CP-55,940. The CBM SCRAs showed binding affinities of Ki : 29.4-0.65 nm and potencies of EC50 : 483-40.1 nm (CBMICA << CBMINACA < CBMeGaClone). The norbornyl derivatives exhibited high affinities (Ki : 1.87-0.25 nm), with indazole being the most affine. Functional activity data confirmed that the indazole derivative tends to be the most potent of all three NBM SCRAs (EC50 : 169-1.78 nm). The sterically demanding NBM side chain increased the affinity and activity of almost all core structures. Future studies should be conducted on similarly voluminous side chain moieties. The 'life cycle' of all SCRAs on the drug market was less than a year. Notably, Cumyl-CBMICA was the most prevalent while also having the weakest cannabimimetic properties. Quantification of Cumyl-CBMICA during peak consumption in late 2019 and early 2020 revealed an increase in the concentration on the herbal material, which, together with forum entries and blog posts, corroborates the low in vitro cannabimimetic properties. Seizure prevalence data indicate that almost all SCRAs continue to be identified in 2022, potentially due to remaining stocks.


Asunto(s)
Agonistas de Receptores de Cannabinoides , Indazoles , Agonistas de Receptores de Cannabinoides/química , Prevalencia , Indazoles/farmacología , Alemania/epidemiología , Receptor Cannabinoide CB1
2.
Drug Test Anal ; 15(1): 84-96, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36136085

RESUMEN

Synthetic cathinones comprise psychostimulants with desired effects like euphoria, increased vigilance, appetite suppression, and-mainly depending on certain structural features-entactogenic properties. 3,4-EtPV (1-(bicyclo[4.2.0]octa-1,3,5-trien-3-yl)-2-(pyrrolidin-1-yl)pentan-1-one) was first mentioned in an online drug forum in September 2021, where its imminent synthesis was announced. The goal was to produce a legal alternative to the phenylethylamines already banned by the German NpSG. In February and June 2022, two samples labeled with the name and molecular structure of 3,4-EtPV were analyzed. The molecular structure of the obviously mislabeled compound was elucidated and comprehensively characterized within the ADEBAR project. The synthetic cathinone identified differed from the declared 3,4-EtPV by a 3,4-propylene bridge instead of a 3,4-ethylene bridge and a piperidine ring instead of a pyrrolidine ring. The short name 3,4-Pr-PipVP (3,4-propylene-2-(1-piperidinyl)valerophenone) was suggested as a semisystematic name in collaboration with the European Monitoring Centre for Drugs and Drug Addiction. Herein, the results of the analyses are discussed and will enable forensic laboratories to update their databases quickly and identify 3,4-Pr-PipVP confidently. 3,4-Pr-PipVP is already scheduled under the German NpSG. This study highlights that there are ongoing efforts to deliberately circumvent generic definitions given, for example, in the German NpSG and that (unintentional?) mislabeling can be an issue. The end user purchasing substances online can never be sure that the material actually supplied will be the one ordered, and he might receive an illicit drug instead of an uncontrolled one. Furthermore, the purity is always unknown, creating health risks due to unexpected effects and potencies.


Asunto(s)
Alcaloides , Drogas Ilícitas , Masculino , Humanos , Cathinona Sintética , Psicotrópicos/química , Alcaloides/análisis , Drogas Ilícitas/química
3.
Drug Test Anal ; 14(8): 1491-1502, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-35524160

RESUMEN

Novel substances for which none or limited analytical data are available constitute a challenge for police and customs forensic laboratories. The time-consuming process of structural elucidation and acquisition of analytical data has been centralized in the ADEBAR project in Germany, co-funded since 2017 by the EU's Internal Security Fund. The project aims to comprehensively characterize substances relevant for forensic-toxicological casework within the analytical competence network. The analytical datasets are distributed digitally through European and (inter)national channels. Additionally, pharmacological evaluation allows for estimating in vivo potency and potential harm required as scientific evidence for legislative amendments. The ADEBAR project contributes to the availability of analytical data on new substances relevant to the daily work of police and customs laboratories. Since the inception of the ADEBAR project, 549 samples have been registered, and 302 substance reports notified to the EMCDDA, including numerous spectrometric and spectroscopic data. In addition, 3,619 mass spectra have been accumulated in ADEBAR mass spectra databases. A central institution for the structure elucidation and acquisition of valid, high-quality analytical data for police and customs forensic laboratories and forensic medicine institutes is important in the future because there does not seem to be an end to the dynamic of novel NPS appearing on the drug market.


Asunto(s)
Psicotrópicos , Toxicología Forense , Alemania , Espectrometría de Masas , Psicotrópicos/análisis , Análisis Espectral
4.
J Pharm Biomed Anal ; 213: 114690, 2022 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-35240405

RESUMEN

A look over the horizon shows that the excellent principle of quantitative NMR spectroscopy can also be applied to unreceptive quadrupolar nuclei. Drugs are often present as HCl or HBr salts. The nuclei 35Cl and 79Br can also be excellently determined qualitatively and quantitatively by NMR when they are present in ionic form. External calibration is used, which has proven to be extremely stable. The validation parameters of the methods already accredited to ISO 17025 are given. The methods proved to be extremely robust. The analyses can be performed practically on-the-fly. This means that the analysis can be carried out within a few minutes in addition to the actual quantitative determination of the organic components without further sample preparation.


Asunto(s)
Bromuros , Cloruros , Calibración , Espectroscopía de Resonancia Magnética/métodos , Sales (Química)
5.
Drug Test Anal ; 14(8): 1387-1406, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-35338591

RESUMEN

New chemical moieties continue to appear in synthetic cannabimimetics (SC), the largest group of new psychoactive substances in the EU. We describe the first comprehensive characterisation of the novel SC Cumyl-Tosyl-Indazole-3-Carboxamide (Cumyl-TsINACA) (N-[2-phenylpropan-2-yl]-1-tosyl-1H-indazole-3-carboxamide) from seized case samples. Structure elucidation was performed within the EU-project ADEBAR plus to facilitate confident identification by other researchers and practitioners worldwide. Characteristic MS fragmentations include the cleavage of the sulfonamide bond (S-N), the aryl sulfone bond (C-S) and the elimination rearrangement of SO2 in the side chain. Cumyl-TsINACA is a full receptor agonist at hCB1 (Emax  = 228%) with very weak binding affinity (Ki  = 292 nm) and low functional activity (EC50  = 31 µm). Thermal degradation of Cumyl-TsINACA was observed under GC conditions. The degree to which the tosyl side chain is cleaved due to pyrolysis primarily depends on solvent, the use of glass wool in the liner and injector temperature. The determination of the constitution by NMR spectroscopy was ambiguous due to the high number of neighbouring, non-proton-bearing atoms. Therefore, other possible structures compatible with the NMR correlations were generated using the WebCocon software. The unambiguous structural evidence was finally obtained by spectra comparison after the synthesis of Cumyl-TsINACA. The low thermal stability, as well as the low affinity and potency, renders this compound unfavourable for the use as a psychoactive substance. Thus, we do not expect widespread adoption of this SC.


Asunto(s)
Cannabinoides , Indazoles , Cannabinoides/metabolismo , Alemania , Indazoles/química , Espectroscopía de Resonancia Magnética
6.
Data Brief ; 39: 107628, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34988267

RESUMEN

Synthetic cannabimimetics (SC) are a diverse group of new psychoactive substances with varying potency and harm potential. New SCs appear on the drug market every year, and reliable and correct identification of these new derivatives independent from the matrix relies on the availability of verified spectra. Three new synthetic cannabimimetics featuring a norbornyl methyl side chain and varying core structure elements were identified in different seizures and forms. Cumyl-BC[2.2.1]HpMeGaClone and Cumyl-BC[2.2.1]HpMINACA were laced onto herbal blends, whereas Cumyl-BC[2.2.1]HpMICA was seized as a pure solid powder. The data collection process involves a comprehensive set of orthogonal analytical techniques allowing for the unambiguous identification of the respective endo- and exo-isomers. Furthermore, the diversity of analytical techniques allows a greater number of laboratories working in the field of forensic chemistry to confidently identify the substances described in our original research article [1]. Structure elucidation and analytical characterisation were performed within the EU-project ADEBAR plus using gas chromatography-mass spectrometry (GC-MS), gas chromatography-solid state infrared spectroscopy (GC-sIR), as well as solid and neat IR spectroscopy, Raman spectroscopy, liquid chromatography-electrospray ionisation-mass spectrometry (LC-ESI-MS), and high resolution (HR)-LC-ESI-MS, and nuclear magnetic resonance (NMR) spectroscopy. The raw analytical data files are included in the Mendeley repository alongside the individual spectra in a universally importable format. The use of the universal JCAMP format for storage of the spectra facilitates database maintenance and enables seamless integration of the verified spectra. Thus, the dataset enables other researchers worldwide to identify these three new SCs confidently.

7.
Drug Test Anal ; 13(1): 208-216, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33037749

RESUMEN

Since the beginning of the phenomenon of new psychoactive substances (NPS), synthetic cannabinoid receptor agonists (SCRAs) have been the largest and most prevalent subclass of these drugs in Europe. Many countries implemented specific legislation scheduling classes of substances defined on the basis of their chemical structure to reduce supply. We describe the identification and analytical characterization within the EU project ADEBAR plus of 1-(cyclobutylmethyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide which resulted in the formal notification through the Early Warning System of the European Monitoring Centre for Drug and Drug Addiction (EMCDDA). This is the first identification of this new SCRA worldwide and the analytical data was distributed (inter-)nationally right after identification in 2019. First, the substance was isolated from the herbal material using preparative high-performance liquid chromatography (HPLC). Structure elucidation and analytical characterization were performed using gas chromatography-mass spectrometry (GC-MS), gas chromatography-solid state infrared spectroscopy (GC-sIR), liquid chromatography-electrospray ionization-quadrupole time of flight-mass spectrometry (LC-ESI-qToF-MS), Raman spectroscopy, and nuclear magnetic resonance (NMR) spectroscopy. The new compound contains a cyclobutyl methyl group as a side chain and has not been described in any patent to our knowledge. Based on the semisystematic nomenclature of SCRAs, we propose Cumyl-CBMICA as a short name for the compound.


Asunto(s)
Agonistas de Receptores de Cannabinoides/análisis , Drogas Ilícitas/análisis , Cromatografía Líquida de Alta Presión , Cromatografía de Gases y Espectrometría de Masas , Plantas Medicinales/química , Espectrometría Raman
8.
J Pharm Biomed Anal ; 177: 112847, 2020 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-31505431

RESUMEN

The quantification of a drug, its impurities, and e.g. components of a mixture has become routine in NMR laboratories and many applications have been described in the literature. However, besides simply using 1D 1H or 13C NMR, a number of more advanced methods has been developed and used in the past. Here, we want to describe the applicability of nuclei beyond the classical ones 1H and 13C. Mixtures can be characterized much better by applying various chemometric methods and separating the signals of mixture components can be achieved by DOSY experiments. All these methods contribute to the platform of qNMR methods and extend the possibilities of NMR for quantification and quality evaluation of drugs, excipients, polymers, and plant extracts. However, for quantification purposes, validation is always an issue and it is necessary to think about taking NMR related measures which might be different from the ones considered for chromatographic methods.


Asunto(s)
Química Farmacéutica/métodos , Espectroscopía de Resonancia Magnética/métodos , Control de Calidad , Química Farmacéutica/historia , Química Farmacéutica/estadística & datos numéricos , Excipientes/análisis , Excipientes/química , Historia del Siglo XX , Historia del Siglo XXI , Espectroscopía de Resonancia Magnética/historia , Extractos Vegetales/análisis , Extractos Vegetales/química , Polímeros/análisis , Polímeros/química , Publicaciones/historia , Publicaciones/estadística & datos numéricos
9.
Drug Test Anal ; 11(6): 833-846, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30610761

RESUMEN

The greatest challenge for European drug policies is how to effectively respond to the dynamic and constantly changing market for new psychoactive substances (NPS). Even small modifications in the chemical structure of substances often allow circumventing existing laws. Also in prison, the consumption of NPS is rising and there is growing evidence that NPS are responsible for a large share of drug-related problems. Ion mobility spectrometry (IMS) is the technique of choice for trace analysis of illicit drugs or explosives at security points, for example airports. Currently, databases of the reduced mobility (K0 ) values are limited to classical drugs and should be completed with data of emerging NPS. In this article, K0 values, LODs (0.7-3.6 ng) and drift times of 25 synthetic cannabinoids were evaluated. The data were added to existing databases of IMS which were then applied for fast screening in prison. The detection capability of the portable IMS technique was evaluated by the determination of intra-day (0.089%) and inter-day precision (0.004% to 0.14%), systematic error (0.19%), and separation capability for structurally related NPS. The applicability of the methodology was demonstrated by the successful analysis of 12 different pieces of paper impregnated with synthetic cannabinoids, 7 different cosmetics, and 5 food samples (liquids), spiked with a mixture of narcotic drugs and a synthetic cannabinoid. In addition, 14 herbal mixtures and 36 different casework samples from prisons were analyzed provided by the State Office of Criminal Investigation Rhineland-Palatinate (Germany).


Asunto(s)
Cosméticos/análisis , Análisis de los Alimentos/métodos , Drogas Ilícitas/análisis , Espectrometría de Movilidad Iónica/métodos , Papel , Plantas Medicinales/química , Cannabinoides/análisis , Tráfico de Drogas , Análisis de los Alimentos/economía , Humanos , Espectrometría de Movilidad Iónica/economía , Narcóticos/análisis , Prisiones , Factores de Tiempo
10.
Forensic Sci Int ; 233(1-3): 387-92, 2013 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-24314545

RESUMEN

For many years now, Pabst's micro-press has been used in German forensic science laboratories as a valuable addition to methods of comparative analysis of plastic trace evidence. However, it is as yet hardly known in laboratories outside of Germany. The principal reproducibility is demonstrated by a homogeneity check of a raw backing material of defined origin. The illustrated results of a proficiency test emphasise the applicability of the Pabst method for forensic comparisons. The discrimination power of the Pabst method was tested by taking 90 black PVC-backings provided by the FBI Laboratory, i.e. those that could not be discriminated by standard methods. In this way further discriminations could be achieved. In the following, the Pabst method is therefore introduced as a straightforward, inexpensive and useful tool.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...